Adanate is a biotechnology company developing antibodies against key receptors on the surface of both innate and adaptive immune cells. Dual modulation of the body’s immunity could provide a novel treatment strategy that allows for better control of cancer.
| Website | http://www.adanate.com |
| Revenue | $1 million |
| Employees | 3 (1 on RocketReach) |
| Founded | 2017 |
| Address | 11099 N Torrey Pines Rd Ste 290, La Jolla, California 92037, US |
| Industry | Biotechnology Research, Business Services General, Drug Discovery, Business Services, Biotechnology |
| Keywords | Therapeutic Antibodies, Immunotherapy, Biotechnology, Immune System, Receptor Targeting, Targeted Therapy, Innate Immunity, Immunological Research, Drug Development, Antibody Engineering, Precision Medicine, Pharmaceutical Research, Protein Engineering, Biologics, Biopharma, Clinical Trials |
| Competitors | Amazon, Zazzle, Printful, Redbubble, Tradersway, Society6, TeePublic, Threadless, CafePress Business +59 more (view full list) |
| SIC | SIC Code 87 Companies, SIC Code 873 Companies |
| NAICS | NAICS Code 541 Companies, NAICS Code 54171 Companies, NAICS Code 5417 Companies, NAICS Code 54 Companies, NAICS Code 541714 Companies |
Looking for a particular Adanate employee's phone or email?
The Adanate annual revenue was $1 million in 2026.
Alice Gois is the CEO of Adanate.
1 people are employed at Adanate.
Adanate is based in La Jolla, California.
The NAICS codes for Adanate are [541, 54171, 5417, 54, 541714].
The SIC codes for Adanate are [87, 873].